Plus Therapeutics
(NASDAQ) PSTV
Plus Therapeutics Financials at a Glance
Market Cap
$19.75M
Revenue (TTM)
$5.21M
Net Income (TTM)
$22.39M
EPS (TTM)
$-32.09
P/E Ratio
-0.11
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Price
$3.57
Volume
5,784
Open
$3.75
Price
$3.57
Volume
5,784
Open
$3.75
Previous Close
$3.57
Daily Range
$3.36 - $3.75
52-Week Range
$3.23 - $30.50
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Price
$3.57
Volume
5,784
Open
$3.75
Previous Close
$3.57
Daily Range
$3.36 - $3.75
52-Week Range
$3.23 - $30.50
PSTV News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Plus Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
28
CEO
Marc H. Hedrick, MD, MBA
Website
www.plustherapeutics.comHeadquarters
Austin, TX 78756, US
PSTV Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
-3%
Net Income Margin
-4%
Return on Equity
0%
Return on Capital
-4%
Return on Assets
-1%
Earnings Yield
-9.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$19.75M
Shares Outstanding
5.55M
Volume
5.78K
Short Interest
0.00%
Avg. Volume
409.18K
Financials (TTM)
Gross Profit
$4.77M
Operating Income
$15.30M
EBITDA
$14.85M
Operating Cash Flow
$20.77M
Capital Expenditure
$67.00K
Free Cash Flow
$20.84M
Cash & ST Invst.
$8.76M
Total Debt
$821.00K
Plus Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.37M
-3.2%
Gross Profit
$1.27M
+8.1%
Gross Margin
93.27%
N/A
Market Cap
$19.75M
N/A
Market Cap/Employee
$940.35K
N/A
Employees
21
N/A
Net Income
$5.71M
-46.4%
EBITDA
$2.33M
+35.6%
Quarterly Fundamentals
Net Cash
$7.94M
+3220.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$15.00K
-51.6%
Short Term Debt
$806.00K
-75.8%
Return on Assets
-1.37%
N/A
Return on Invested Capital
-3.81%
N/A
Free Cash Flow
$6.29M
-414.5%
Operating Cash Flow
$6.26M
-416.7%